Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment (Q38862736)

7 September 2017

1 reference

title

Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment (English)

1 reference

7 September 2017

main subject

Guillain–Barré syndrome

0 references

author

Juan-Manuel Anaya

5

1 reference

7 September 2017

Carlo Selmi

2

0 references

M. Eric Gershwin

6

object named as

M Eric Gershwin

1 reference

7 September 2017

Anil K Jasti

1

1 reference

7 September 2017

Juan C Sarmiento-Monroy

3

1 reference

7 September 2017

Daniel A Vega

4

1 reference

7 September 2017

publication date

13 June 2016

1 reference

Expert Review of Clinical Immunology

7 September 2017

published in

1 reference

7 September 2017

volume

12

1 reference

7 September 2017

issue

11

1 reference

7 September 2017

page(s)

1175-1189

1 reference

An acute axonal form of Guillain-Barré polyneuropathy

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

The immunobiology of Guillain-Barré syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

21 January 2018

Guillain–Barré Syndrome

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Immunotherapy for Guillain-Barre syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

The immunogenetics of multiple sclerosis: A comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

From defining antigens to new therapies in multiple sclerosis: honoring the contributions of Ruth Arnon and Michael Sela

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Epidemiologic features of Guillain-Barré syndrome in São Paulo, Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Subtypes and Prognosis of Guillain-Barré Syndrome in Southwest China

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Patterns of Guillain-Barre syndrome in children: results from a Mexican population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Is there a decrease in Guillain-Barré syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy, 1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barré syndrome in Spain, 1985-1997: epidemiological and public health views

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Public health surveillance and incidence of adulthood Guillain-Barré syndrome in Spain, 1998-1999: the view from a sentinel network of neurologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Why delaying levodopa is a good treatment strategy in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Clinical and epidemiologic features of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Incidence of Guillain-Barré syndrome among patients with Campylobacter infection: a general practice research database study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Infectious and noninfectious triggers in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Preceding infections, immune factors, and outcome in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Cluster of atypical adult Guillain-Barré syndrome temporally associated with neurological illness due to EV-D68 in children, South Wales, United Kingdom, October 2015 to January 2016.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Zika virus and Guillain-Barré syndrome: another viral cause to add to the list

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain–Barré Syndrome—A Classical Autoimmune Disease Triggered by Infection or Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barré syndrome subtypes related to Campylobacter infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Acute motor axonal neuropathy after Mycoplasma infection: Evidence of molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Syndromic surveillance for influenzalike illness in ambulatory care network

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Ambiguous value of Haemophilus influenzae isolation in Guillain-Barre and Fisher syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Neuropsychiatric manifestations of typhoid fever in 959 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barré syndrome associated with Salmonella paratyphi A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barré syndrome associated with resistant cytomegalovirus infection after face transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

CMV-associated axonal sensory-motor Guillain-Barré syndrome in a child: Case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

A rare case of infectious mononucleosis complicated by guillain-barre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Overlapping Guillain-Barré syndrome and Bickerstaff's brainstem encephalitis associated with Epstein Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Early-onset Guillain-Barré syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barré syndrome following chickenpox: a case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barré syndrome and influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barré syndrome associated with the D222E variant of the 2009 pandemic influenza A (H1N1) virus: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Sensori-motor Guillain-Barré syndrome with anti-GD1b antibodies following influenza A infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

How do viral infections predispose patients to bacterial infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

HIV infection presenting with motor axonal variant of Guillain-Barré Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Fisher/Gullain–Barré overlap syndrome in advanced AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

HIV-associated Guillain-Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Neurologic dengue manifestations associated with intrathecal specific immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Acute inflammatory demyelinating polyradiculoneuropathy (Guillain-Barré syndrome) following dengue fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barré syndrome in the course of dengue: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Oligosymptomatic dengue infection: a potential cause of Guillain Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Acute neuromuscular weakness associated with dengue infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Neurological manifestations of dengue infection: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barre syndrome following dengue fever and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Increase in cases of Guillain-Barré syndrome during a Chikungunya outbreak, French Polynesia, 2014 to 2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barré syndrome after Chikungunya infection: A case in Colombia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Emergence and clinical insights into the pathology of Chikungunya virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barré Syndrome after Chikungunya Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

[Neurological manifestations in Chikungunya: about 23 cases collected in Reunion Island].

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barré syndrome complicating a Chikungunya virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Zika virus and neurologic autoimmunity: the putative role of gangliosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Zika virus: History, emergence, biology, and prospects for control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Zika virus detection in urine from patients with Guillain-Barré syndrome on Martinique, January 2016.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Study links Zika virus to Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

The Zika outbreak of the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Local Transmission of Zika Virus — Puerto Rico, November 23, 2015–January 28, 2016

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Zika virus: a previously slow pandemic spreads rapidly through the Americas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Identification of Zika virus vectors and implications for control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Current Zika virus epidemiology and recent epidemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Time for global action on Zika virus epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

The Guillain-Barré syndrome: a true case of molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain-barré syndrome animal model: the first proof of molecular mimicry in human autoimmune disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

21 January 2018

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

TH1 and TH2 response to Campylobacter jejuni antigen in Guillain-Barre syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Localization of major gangliosides in the PNS: implications for immune neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Neuromuscular transmission is not impaired in axonal Guillain-Barre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Ganglioside complexes as new target antigens in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

The spectrum of immune-mediated autonomic neuropathies: insights from the clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain–Barré syndrome associated with normal or exaggerated tendon reflexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Differences in patterns of progression in demyelinating and axonal Guillain-Barré syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Autonomic function in demyelinating and axonal subtypes of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Axonal Guillain-Barré syndrome: concepts and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

A fulminant case of Guillain-Barré syndrome: topographic and fibre size related analysis of demyelinating changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Anti-GT1a IgG in Guillain-Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain–Barré and Miller Fisher syndromes—new diagnostic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Guillain–Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Diagnostic value of lumbar root stimulation at the early stage of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Spinal nerve involvement in early Guillain-Barré syndrome: a clinico-electrophysiological, ultrasonographic and pathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Ultrasound and electrophysiologic findings in patients with Guillain-Barré syndrome at disease onset and over a period of six months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Admission neurophysiological abnormalities in Guillain-Barré syndrome: A single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Sural sparing pattern discriminates Guillain-Barré syndrome from its mimics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Electrodiagnostic criteria for Guillain–Barrè syndrome: A critical revision and the need for an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Mimics and chameleons in Guillain-Barré and Miller Fisher syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Pearls and pitfalls in the intensive care management of Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Respiratory aspects of neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Erythropoietin enhances nerve repair in anti-ganglioside antibody-mediated models of immune neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Anti-ganglioside antibody-mediated activation of RhoA induces inhibition of neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Intravenous immunoglobulin therapy for Miller Fisher syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Mortality in mechanically ventilated patients of Guillain Barré Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Primary biliary cirrhosis and Sjögren's syndrome: autoimmune epithelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Criteria for environmentally associated autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Mechanisms of environmental influence on human autoimmunity: a National Institute of Environmental Health Sciences expert panel workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

The role of environmental factors in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Heritability versus the role of the environment in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Engineering of synthetic cellular microenvironments: implications for immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Natural Th17 cells are critically regulated by functional medullary thymic microenvironments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Twin studies in autoimmune disease: genetics, gender and environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

The X in sex: how autoimmune diseases revolve around sex chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Epigenetics and the IRFs: a complex interplay in the control of immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

The epigenetics of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Epigenetics in autoimmune disorders: highlights of the 10th Sjögren's syndrome symposium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

Acute motor axonal neuropathy: An antibody-mediated attack on axolemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1744666X.2016.1193006

10.1080/1744666X.2016.1193006

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference